Sign in
SuspendedNo phase

Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia

Key facts

Who runs it
University of Southern California
Where
Los Angeles, United StatesSee the site
Trial code
Status
Suspended
People taking part
1,000 people, planned
Started
1 May 2026
Expected to end
30 Aug 2027
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Risk Assessment Screening
  • Coach and Website Intervention
Record updated
24 February 2026
Why it stopped
Study paused per IRB request.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • 18 years old or older
  • Speak English or Spanish
  • Caregiver for a person with Alzheimer's Disease or another type of dementia
  • Provide substantial care for this person, defined as assisting with at least one activity of daily living or two instrumental activities of daily living
  • See this person at least twice a week
  • Have access to the internet

Who cannot take part

  • Caregiver for person who does not have dementia
  • Primary relationship between caregiver and person with dementia is that of a professional paid caregiver
  • Under 18 years old
  • Speak language besides English or Spanish
  • Do not provide substantial care for this person
  • Enrolled in another caregiver study

Where in United States

  • Keck MedicineLos Angeles, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to test a risk assessment screening and intervention for caregivers of people with dementia. The main questions it aims to answer are:

Read full original descriptionShow less

1. What are the harms and benefits of administering the elder abuse risk assessment screening? 2. What are the harms and benefits of administering the caregiver intervention?

Researchers will compare participants who receive the screening and caregiver intervention to a group who does not receive the caregiver intervention and a group who receives neither the screening or the caregiver intervention to answer these questions.

Participants will:

* Complete two surveys, three months apart * Complete a 5-item screening tool, if assigned to one of the screening groups * Complete a 3-session caregiver intervention, if assigned to that group

The 3 groups in the trial

  • ControlNo study treatment, for comparison

    Participants will receive no intervention, only the two study surveys.

  • Risk Assessment Screening OnlyTreatment being tested

    Participants will complete the risk assessment screening along with the two study surveys.

    Treatment: Risk Assessment Screening

  • Risk Assessment Screening and Coach InterventionTreatment being tested

    Participants will complete the risk assessment screening, three coach sessions, intervention website, and the two study surveys.

    Treatment: Risk Assessment Screening and Coach and Website Intervention

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
24 February 2026